Bayesian spatio-temporal analysis and geospatial risk factors of human monocytic ehrlichiosis. [PDF]
Variations in spatio-temporal patterns of Human Monocytic Ehrlichiosis (HME) infection in the state of Kansas, USA were examined and the relationship between HME relative risk and various environmental, climatic and socio-economic variables were ...
Ram K Raghavan +4 more
doaj +7 more sources
Human Monocytic Ehrlichiosis, Mexico City, Mexico [PDF]
Little information is available about human infections by the members of the genus Ehrlichia in Mexico. Only 2 species, Ehrlichia canis and E. chaffensis, are known to cause disease in this country.
Virginia E. Alcántara-Rodríguez +8 more
doaj +5 more sources
Human Monocytic Ehrlichiosis Associated With Myocarditis and Hemophagocytic Lymphohistiocytosis [PDF]
We present 3 cases at a single institution of human monocytic ehrlichiosis resulting in myocarditis and hemophagocytic lymphohistiocytosis. Contrary to previously published studies in which case fatalities were only as high as 1%, 2 of the 3 patients we ...
Cherie N. Dahm, MD, BSN +4 more
doaj +4 more sources
Large-scale health disparities associated with Lyme disease and human monocytic ehrlichiosis in the United States, 2007-2013. [PDF]
Promoting health equity is a fundamental public health objective, yet health disparities remain largely overlooked in studies of vectorborne diseases, especially those transmitted by ticks.
Yuri P Springer, Pieter T J Johnson
doaj +4 more sources
Human monocytic ehrlichiosis complicated by hemophagocytic lymphohistiocytosis and multi-organ dysfunction syndrome. [PDF]
Human monocytic ehrlichiosis can manifest as a disease causing multi-organ failure. Rarely, it can cause secondary hemophagocytic lymphohistiocytosis (HLH). Early diagnosis and initiation of treatment for both ehrlichiosis and HLH is lifesaving. Therefore, clinical suspicion of HLH must remain high in the setting of an ehrlichiosis infection.
Kaplan RM, Swat SA, Singer BD.
europepmc +5 more sources
Serologic Evidence of Human Monocytic and Granulocytic Ehrlichiosis in Israel
We conducted a retrospective serosurvey of 1,000 persons in Israel who had fever of undetermined cause to look for Ehrlichia chaffeensis antibodies. Four of five cases with antibodies reactive to E.
Avi Keysary +8 more
doaj +5 more sources
Current management of human granulocytic anaplasmosis, human monocytic ehrlichiosis and Ehrlichia ewingii ehrlichiosis. [PDF]
Anaplasma phagocytophilum, Ehrlichia chaffeensis and Ehrlichia ewingii are emerging tick-borne pathogens and are the causative agents of human granulocytic anaplasmosis, human monocytic ehrlichiosis and E. ewingii ehrlichiosis, respectively. Collectively, these are referred to as human ehrlichioses.
Thomas RJ, Dumler JS, Carlyon JA.
europepmc +5 more sources
Successful Treatment of Human Monocytic Ehrlichiosis with Rifampin. [PDF]
Currently recommended treatment regimens for human monocytic ehrlichiosis (HME) include doxycycline or tetracycline. Antibiotic susceptibility studies demonstrate that rifampin has in vitro bactericidal activity against Ehrlichia. Case reports have suggested clinical response with rifampin treatment of human granulocytic anaplasmosis (HGA).
Abusaada K, Ajmal S, Hughes L.
europepmc +4 more sources
A case of human monocytic ehrlichiosis in Serbia [PDF]
Introduction. Ehrlichiosis is a bacterial zoonosis transmitted by hematophagous arthropods - ticks. In humans, it occurs as monocytic, granulocytic, and ewingii ehrlichiosis.
Arsić Bogdan +6 more
doaj +4 more sources
An Entry-Triggering Protein of
Ehrlichia chaffeensis is an obligatory intracellular bacterium that causes human monocytic ehrlichiosis, an emerging disease transmitted by the Lone Star tick, Amblyomma americanum. E.
Khemraj Budachetri +6 more
doaj +2 more sources

